ArticleBMJ open2023
Progression and incidence of myopia among schoolchildren in the post-COVID-19 pandemic period: a prospective cohort study in Shantou, China.
Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- School and family based myopia education associations with myopia prevalence in Hefei high school students in the post-COVID-19 period.Scientific reports · 2026Article
- Social jet lag and visual acuity decline in junior high students: a retrospective cohort study.Scientific reports · 2026Article
- The incidence of myopia and the factors associated with it among primary and junior high school students in Shihezi, China, a cohort study based on the SHAP model.BMC public health · 2026Observational
- Centile curves of refraction in children and adolescents aged 5-18 in Hubei Province: a study based on GAMLSS to predict refraction development.International journal of ophthalmology · 2026Article
- Myopia and daylight-A combination of factors.Frontiers in medicine · 2025Article
- Epidemiological characteristics of myopia among school-age children before, during, and after the COVID-19 pandemic: a cohort study in Shenzhen, China.Frontiers in medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo determine the progression and incidence of myopia in Chinese schoolchildren in the post-COVID-19 pandemic period in Shantou, China.
designProspective cohort study.
settingShantou Myopia Study, China.
participants1-year follow-up data were available for 621 881 schoolchildren (301 999 females). Data on spherical equivalent refraction (SER) were collected. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcomes were myopia progression and incidence. Myopia progression is defined as a change of SER towards the negative direction in the follow-up visit. Incidence is defined as the proportion of schoolchildren who were not myopic but developed myopia in the follow-up study. Age, sex and SER at baseline were evaluated as associated factors for myopia burden, which were defined as the secondary outcomes.
resultsMean progression of SER was -0.35±0.97 D for the population (ranging from -0.06 D at 18 years of age to -0.46 D at 11 years of age), with a rapid myopic progression for students at the age of 10-12 years (-0.50 D in girls and -0.44 D in boys). A myopic shift greater than -0.50 D/year occurred in 256 299 eyes (41.21%). Myopic progression in refraction was associated with the 10-12 years age groups (OR 1.42; 95% CI 1.39 to 1.45, p<0.001), female sex (OR 1.09; 95% CI 1.08 to 1.10, p<0.001) and higher refractive errors at baseline (OR>1.00, p<0.001). The annual incidence of myopia among schoolchildren was 24.85%, with an incidence of 26.69% in girls and 23.02% in boys.
conclusionsOur study revealed an annual myopia progression of -0.35 D and an incidence of 24.85% among schoolchildren in the post-COVID-19 pandemic period. Myopia progressed rapidly at 10-12 years of age, with -0.50 D in girls and -0.44 D in boys. The incidence was higher for children aged 10-11 years and for girls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.